Emalex Biosciences
Biotechnology Research
330 N Wabash Ave
39 employees
- Employees
- 39
- Contacts
- 3
- Emails
- 3
- Phones
- 3
Emalex Biosciences Overview
- Headquarters
- 330 N Wabash Ave
- Website
- emalexbiosciences.com
- Industry
- Biotechnology Research
- Employees
- 39
- Founded
- 2018
- Funding
- 270.0M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Emalex Biosciences
Emalex Biosciences is in late-stage development for a new class of drug for patients with Tourette syndrome and other neurological disorders.
Emalex Biosciences Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 3
- 75.0% coverage
Emalex Biosciences Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Brent Paul | Executive Commercial Healthcare Leader | Greater Chicago Area, United States |
Email
Phone
|
| Ricky Sun | Partner, Bain Capital Life Sciences | Greater Boston, United States |
Email
Phone
|
| Prathibha H. | Statistical Programming Leader | Redmond, Washington, United States |
View
|
| Tim Rudolphi | Biotech - Digital Health - Strategy | Greater Chicago Area, United States |
Email
Phone
|
Employees by Management Level
Individual contributor
5 profiles
Compare Similar Companies to Emalex Biosciences
Harmony Biosciences
Pharmaceutical Manufacturing
Prenosis
Biotechnology Research
Stoelting Co.
Biotechnology Research
World Bioproducts LLC
Biotechnology Research
Amlan International
Biotechnology Research
Dimension Bio
Biotechnology Research
Paragon Biosciences
Biotechnology Research
Xentria, Inc.
Biotechnology Research
Daigger Scientific
Biotechnology Research
Monopar Therapeutics Inc.
Biotechnology Research